Time-dependent effects of endogenous hyperglucagonemia on glucose homeostasis and hepatic glucagon action
JCI Insight · 2023
DOI: 10.1172/jci.insight.162255 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, 2023. Verfasst von Camila Lubaczeuski und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division Endocrinology, Metabolism and Diabetes, Miller School of Medicine, University of Miami, Miami, Florida, USA. Hauptthemen laut MEDLINE: Hypoglycemia, Glucose Intolerance. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, NIDDK NIH HHS, BLRD VA.
Abstract (Originalsprache)
Elevation of glucagon levels and increase in α cell proliferation is associated with states of hyperglycemia in diabetes. A better understanding of the molecular mechanisms governing glucagon secretion could have major implications for understanding abnormal responses to hypoglycemia in patients with diabetes and provide novel avenues for diabetes management. Using mice with inducible induction of Rheb1 in α cells (αRheb Tg mice), we showed that short-term activation of mTORC1 signaling is sufficient to induce hyperglucagonemia through increased glucagon secretion. Hyperglucagonemia in αRheb Tg mice was also associated with an increase in α cell size and mass expansion. This model allowed us to identify the effects of chronic and short-term hyperglucagonemia on glucose homeostasis by regulating glucagon signaling in the liver. Short-term hyperglucagonemia impaired glucose tolerance, which was reversible over time. Liver glucagon resistance in αRheb Tg mice was associated with reduced expression of the glucagon receptor and genes involved in gluconeogenesis, amino acid metabolism, and urea production. However, only genes regulating gluconeogenesis returned to baseline upon improvement of glycemia. Overall, these studies demonstrate that hyperglucagonemia exerts a biphasic response on glucose metabolism: Short-term hyperglucagonemia lead to glucose intolerance, whereas chronic exposure to glucagon reduced hepatic glucagon action and improved glucose tolerance
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division Endocrinology, Metabolism and Diabetes, Miller School of Medicine, University of Miami, Miami, Florida, USA.
- Veterans Affairs Ann Arbor Healthcare System, Research Service, Ann Arbor, Michigan, USA.
- Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA.
- Childrens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
- Diabetes Unit and Endocrine Service, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Förderung
- NCATS NIH HHS
- NIDDK NIH HHS
- BLRD VA
- Veterans Administration
- National Institutes of Health
Zitieren
APA
Lubaczeuski, C., Bozadjieva-Kramer, N., Louzada, R. A., Gittes, G. K., Leibowitz, G., & Bernal-Mizrachi, E. (2023). Time-dependent effects of endogenous hyperglucagonemia on glucose homeostasis and hepatic glucagon action. JCI Insight. https://doi.org/10.1172/jci.insight.162255
Vancouver
Lubaczeuski C, Bozadjieva-Kramer N, Louzada RA, Gittes GK, Leibowitz G, Bernal-Mizrachi E. Time-dependent effects of endogenous hyperglucagonemia on glucose homeostasis and hepatic glucagon action. JCI Insight. 2023. doi:10.1172/jci.insight.162255
BibTeX
@article{Lubaczeuski2023,
author = {Lubaczeuski, Camila and Bozadjieva-Kramer, Nadejda and Louzada, Ruy A and Gittes, George K and Leibowitz, Gil and Bernal-Mizrachi, Ernesto},
title = {Time-dependent effects of endogenous hyperglucagonemia on glucose homeostasis and hepatic glucagon action},
journal = {JCI Insight},
year = {2023},
doi = {10.1172/jci.insight.162255}
}
EUVIMED